Autopsy report · NCT00589238
Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery
Cause of deathNo reason given
Life of this trial
- 16 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- National Cancer Centre, Singapore
- Sponsor type
- University, hospital or other
- Conditions
- Breast Cancer
- Interventions
- carboplatin; cyclophosphamide; doxorubicin hydrochloride; paclitaxel
- Participants
- 16
- Sites
- 2
- Countries
- Singapore
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.